In 2022, Worldwide Breast Imaging Market was worth $4.5 billion US dollars. AMR Group projects that the market will reach US$ 8.7 billion by 2031, growing at a CAGR of 8.5 percent between 2023 and 2031.
Industry Overview
Breast imaging is a diagnostic imaging specialized field that uses irradiation or non-ionizing radiation to detect tumor nodules in the breast. This method enables health professionals to conduct early diagnosis before symptoms appear. Besides this, extensive research in the development of hybrid imaging systems provides significant growth opportunities for global breast imaging market participants. Some of the most common breast imaging tests are mammograms, breast magnetic resonance imaging (MRI), and ultrasound. Moreover, computed tomography (CT) scans and position emission tomography (PET) are recommended for breast cancer diagnosis. Mammography is a type of breast imaging technology that uses low-dose X-rays to detect cancer at an early stage, before symptoms appear.
According to the WHO, there are 2.3 million women diagnosed with breast cancer in 2020, with 685 000 deaths worldwide. By the end of 2020, 7.8 million women had already been diagnosed with breast cancer in the previous five years, making it one of the world’s most common types of cancer. Moreover, according to Breast Cancer.org, approximately 43,300 women in the United States were also expected to die from breast cancer in 2022. Since 2007, mortality rates among women under 50 have remained stable, while rates among women over 50 have continued to fall. From 2013 to 2018, the overall rate of breast cancer death decreased by 1% per year.
Market Dynamics
The Breast Imaging market tends to grow due to the increasing prevalence of cancer across the globally. The rise in the number of breast cancer cases worldwide has led to the increase in the usage of a variety of breast screenings processes like breast MRI, Molecular breast imaging, breast tomosynthesis, Positron emission mammography, Contrast-enhanced mammography, Electrical impedance imaging, gynecomastia ultrasound, Elastography, mastitis ultrasound, gynecomastia radiology, breast sonogram, galactocele radiology, fibrocystic breast disease radiology, breast cancer radiology, fibroadenoma radiology which are also boosting the overall market growth.
In recent years, there is technological advancements in breast screening, a rising number of conferences worldwide on spreading awareness regarding the benefits of early screening and diagnosis, the increased investments of government and private firms to meet the rising requirements for breast cancer screening, along with the excellent cancer screening reimbursement policies are widely influencing the market’s growth globally. Whereas the high cost required in the diagnosis process and lack of skilled staff are some of the restraining factors which hamper the market.
Click Here To Access The Free Sample Report @ https://analyticsmarketresearch.com/sample-request/breast-imaging-market/10959/
COVID Impact
The COVID-19 pandemic has highly impacted the Breast Imaging market due to the sudden decrease in the number of people getting screened for cancer detection during the pandemic. In the U.S., screenings for breast cancer, colon cancer, and cervix cancer reduced by 94%, 86%, and 94% between 20th January 2020 and 21st April 2020, respectively. Many cancer screening facilities closed temporarily, while rest issued a severe staffing shortages. Also, in Europe, cancer detection services were disrupted by 50% till the end of 2021. People were afraid to go to hospitals & other medical facilities for non-emergency procedures due to the rise of COVID-19, which negatively affected Breast cancer screening practices.
Regional Trend
Geographically, the global Breast Imaging market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Globally, North America dominates the Breast Imaging market due to the factors such as the rising prevalence of Breast Cancers, advancement in diagnostics and availability of different treatment options for cancers, established healthcare system, rising investment in Breast Imaging, high healthcare expenditure, and increasing demand for preventive medical care. Asia Pacific is anticipated to register a higher CAGR due to increasing incidences & awareness of cancer, large patient population, development of advanced technologies, increasing disposable incomes, greater awareness and developing healthcare systems.
Competitive Landscape
Key players operating in the global Breast Imaging market are Aurora Imaging Technology, Inc., Canon Inc., Carestream Health, Inc., CMR Naviscan Corporation, Dilon Technologies, Inc., FUJIFILM Holdings Corporation, Gamma Medica, Inc., GE Healthcare, Hitachi, Ltd., Hologic, Inc., Koninklijke Philips N.V., Planmed Oy, Siemens AG, SonoCine, Inc., and Toshiba Corporation among others. Recently, in 2022, GE Healthcare partnered with the National Cancer Centre Singapore (NCCS). This partnership was made to stimulate the possibility of more personalized treatment options for cancer and provide the opportunity to examine clinically vital information during the patient journey by utilization artificial intelligence.
Key USP’s-
In May 2022, QUSTom (Quantitative Ultrasound Stochastic Tomography), a European project was performed by the Barcelona Supercomputing Center (BSC). QUSTom targeted to develop a new medical imaging modality depended upon ultrasound & supercomputing that will supplement or even replace current X-ray-based techniques like mammograms.
Market Segmentation
Based upon the Technology used in tissue detection market is segmented into two major segments Ionizing Technology and Non-Ionizing Technology in the detection process. Henceforth it is bifurcated according to its process & utilization. Based on the Ionizing Technology, the breast imaging segment is bifurcated into Full-Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/Computed Tomography (PET/CT), Molecular Breast-Specific Gamma Imaging (MBI/BSGI), Computed Tomography (CT), Positron Emission Mammography (PEM), Analog Mammography, Cone Beam Computed Tomography (CBCT). The most dominant segment among the others is 3D Breast Tomosynthesis segment which is expected to have the largest share in terms of use and revenue. Based on Non-Ionizing Technology, the breast imaging market is segmented into Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography, and Optical Imaging. Among the Non-Ionizing Technology segments, the Breast Ultrasound segment is expected to grow for the largest share. As the incidences of breast cancer is high and increasing gradually across the globe. With reference to WHO, in 2020, around 2.3 million women were diagnosed with breast cancer globally.
End user segment of tissue detection market is further divided into Hospitals, Diagnostic Imaging Centers, and Ambulatory Surgical Centers. Hospitals & Diagnostic user segment dominated the market in terms of revenue owing to more inclination of patients towards the hospitals due to the rising prevalence of cancer globally.
By Technology
- Ionizing Technology
o Full-Field Digital Mammography (FFDM)
o 3D Breast Tomosynthesis
o Positron Emission Tomography/Computed Tomography (PET/CT)
o Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
o Computed Tomography (CT)
o Positron Emission Mammography (PEM)
o Analog Mammography
o Cone Beam Computed Tomography (CBCT)
- Non-Ionizing Technology
o Breast Ultrasound
o Breast MRI
o Automated Whole-Breast Ultrasound
o Breast Thermography
o Optical Imaging
By End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
Global Breast Imaging Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Breast Imaging market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Read Full Research Report @ https://analyticsmarketresearch.com/reports/breast-imaging-market/10959/
An Overview of the Impact of COVID-19 on Market: The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
The main goals of report are:
- To examine and assignment the extent of the international market for the market sector.
- To Researching the important gamers globally, their SWOT analysis, market value, and market share.
- To identify, describe, and mission market based totally on type, quit use, and geography.
- To take a look at the market advantages, challenges, dangers, and constraints in the world’s principal regions.
- To pick out key traits and variables that are advertising or inhibiting market growth.
- To decide the excessive increase segments in order to have a look at the market potentialities for stakeholders.
- To consider every submarket fastidiously in phrases of its very own boom sample and market contribution.
- To know market possessions, agreements, growth, and the introduction of new merchandise as aggressive advances.
- To strategically discover the essential gamers and completely take a look at their enlargement plans.
